DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane

Molecular and Cellular Biology

Volumn 16, Issue 4, 1996, Pages 1770-1776

  Hasegawa, Hideki ^a,b   Kiyokawa, Etsuko ^a   Tanaka, Shinya ^b   Nagashima, Kazuo ^b   Gotoh, Noriko ^c   Shibuya, Masabumi ^c   Kurata, Takeshi ^a   Matsuda, Michiyuki ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MESSENGER RNA; PROTEIN TYROSINE KINASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CELL STRAIN 3T3; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOLECULAR CLONING; MOUSE; NONHUMAN; ONCOGENE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

EID: 0029926307     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.4.1770     Document Type: Article

References (45)

1. Aronheim, A., D. Engelberg, N. X. Li, N. Alalawi, J. Schlessinger, and M. Karin. 1994. Membrane targeting of the nucleotide exchange factor sos is sufficient for activating the ras signaling pathway Cell 78:949-961.
2. Birge, R. B., J. E. Fajardo, B. J. Mayer, and H. Hanafusa. 1992 Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze crk-phosphotyrosine-dependent interactions in vitro. J. Biol. Chem. 267:10588-10595.
3. Birge, R. B., J. E. Fajardo, C. Reichman, S. E. Shoelson, Z. Songyang, L. C. Cantley, and H. Hanafusa. 1993. Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts. Mol. Cell Biol 13:4648-4656.
4. Clark, E. A., and J. S. Brugge. 1995. Integrins and signal transduction pathways: the road taken Science 268:233-239.
5. Cohen, G. B., R. Ren, and D. Baltimore. 1995. Modular binding domains in signal transduction proteins Cell 80:237-248.
6. Feig, L. A., and B. Schaffhausen. 1994. Signal transduction - the hunt for ras targets. Nature (London) 370:508-509.
7. Feller, S. M., B. Knudsen, and H. Hanafusa. 1995. Cellular proteins binding to the first src homology 3 (SH3) domain of the proto-oncogene product c-crk indicate crk-specific signaling pathways. Oncogene 10:1465-1473.
8. Feller, S. M., R. B. Ren, H. Hanafusa, and D. Baltimore. 1994. SH2 and SH3 domains as molecular adhesives: the interactions of crk and abl. Trends Biochem. Sci. 19:453-458.
9. Gotoh, N., A. Tojo, K. Muroya, Y. Hashimoto, S. Hattori, S. Nakamura, T. Takenawa, Y. Yazaki, and M. Shibuya. 1994. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity. Proc Natl. Acad Sci. USA 91:167-171
10. Gotoh, T., S. Hattori, S. Nakamura, H. Kitajama, M. Noda, Y. Takai, K. Kaibuchi, H. Matsui, O. Hatase, H. Takahashi, T. Kurata, and M. Matsuda. 1995. Identification of Rap1 as a target for Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol. Cell. Biol. 15:6746-6753.
11. Gout, I., R. Dhand, I. D. Hiles, M. J. Fry, G. Panayotou, P. Das, O. Truong, N. F. Totty, J. Hsuan, G. W. Booker, I. D. Campbell, and M. D. Waterfield. 1993 The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell 75:25-36
12. Hasegawa, H., E. Kiyokawa, and M. Matsuda. Unpublished results.
13. Hempstead, B. L., R. B. Birge, J. E. Fajardo, R. Glassman, D. Mahadeo, R. Kraemer, and H. Hanafusa. 1994. Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor-and epidermal growth factor-dependent pathways. Mol. Cell. Biol. 14:1964-1971
14. Higgins, D. G., and P. M. Sharp. 1988. CLUSTAL: a package for performing multiple sequence alignments on a microcomputer. Gene 73:237-244.
15. Holsinger, L. J., D. M. Spencer, D. J. Austin, S. L. Schreiber, and G. R. Crabtree. 1995 Signal transduction in T lymphocytes using a conditional allele of sos Proc. Natl. Acad Sci. USA 92:9810-9814.
16. Juliano, R. L., and S. Haskill. 1993. Signal transduction from the extracellular matrix J. Cell Biol. 120:577-585.
17. Knudsen, B. S., S. M. Feller, and H. Hanafusa. 1994. Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first src homology 3 domain of Crk. J Biol. Chem. 269: 32781-32787.
18. Knudsen, B. S., J. Zheng, S. M. Feller, J. P. Mayer, S. K. Burrell, D. Dowburn, and H. Hanafusa. 1995. Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteins. EMBO J 14:2191-2198.
19. Kozak, M. 1991. An analysis of vertebrate messenger RNA sequences - initiations of translational control. J Cell Biol. 115:887-903.
20. Matsuda, M., Y. Hashimoto, K. Muroya, H. Hasegawa, T. Kurata, S. Tanaka, S. Nakamura, and S. Hattori. 1994 CRK binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells Mol. Cell Biol 14:5495-5500.
21. gag-crk, to a broad range of phosphotyrosine-containing proteins. Science 248:1537-1539.
22. Matsuda, M., S. Tanaka, S. Nagata, A. Kojima, T. Kurata, and M. Shibuya. 1992 Two species of human CRK cDNA encode proteins with distinct biological activities. Mol. Cell. Biol. 12:3482-3489.
23. Matuoka, K., M. Shibata, A. Yamakawa, and T. Takenawa. 1992 Cloning of ASH, a ubiquitous protein composed of one Src homology region (SH)-2 and 2 SH3 domains, from human and rat cDNA libraries. Proc Natl. Acad. Sci. USA 89:9015-9019.
24. Mayer, B. J., M. Hamaguchi, and H. Hanafusa. 1988. A novel viral oncogene with structural similarity to phospholipase C Nature (London) 332:272-275
25. Mayer, B. J., and H. Hanafusa. 1990. Mutagenic analysis of the v-crk uncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation. J. Virol. 64:3581-3589
26. Mayer, B. J., and H. Hanafusa. 1990. Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity. Proc. Natl. Acad. Sci. USA 87:2638-2642.
27. McCoy, M. S., C. I. Bargmann, and R. A. Weinberg. 1984 Human colon carcinoma Ki-ras2 oncogene and its corresponding proto-oncogene. Mol. Cell. Biol. 4:1577-1582.
28. Miki, H., K. Miura, K. Matuoka, T. Nakata, N. Hirokawa, S. Orita, R. Kaibuchi, Y. Takai, and T. Takenawa. 1994. Association of Ash/Grb-2 with dynamin through the SRC homology 3 domain. J. Biol. Chem. 269:5489-5492.
29. Musacchio, A., M. Wilmanns, and M. Saraste. 1994. Structure and function of the SH3 domain. Prog. Biophys Mol. Biol. 61:283-297.
30. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-200.
31. Nojima, Y., N. Morino, T. Mimura, K. Hamasaki, H. Furuya, R. Sakai, T. Sato, K. Tachibana, C. Morimoto, Y. Yazaki, and H. Hirai. 1995. Integrin-mediated cell adhesion promotes tyrosine phosphorylation of p130(cas), a src homology 3-containing molecule having multiple src homology 2-binding motifs J. Biol. Chem. 270:15398-15402.
32. Odai, H., K. Sasaki, A. Iwamatsu, Y. Hanazono, T. Tanaka, K. Mitani, Y. Yazaki, and H. Hirai. 1995. The proto-oncogene product c-cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells. J. Biol. Chem. 270:10800-10805.
33. Ogawa, S., H. Toyoshima, H. Kozutsumi, K. Hagiwara, R. Sakai, T. Tanaka, N. Hirano, H. Mano, Y. Yazaki, and H. Hirai. 1994. The c-terminal SH3 domain of the mouse c-crk protein negatively regulates tyrosine-phosphorylation of crk associated p130 in rat 3Y1 cells. Oncogene 9:1669-1678.
34. Pawson, T. 1995. Protein modules and signalling networks. Nature (London) 373:573-580.
35. Quilliam, L. A., S. Y. Huff, K. M. Rabun, W. Wei, W. Park, D. Broek, and C. J. Der. 1994. Membrane-targeting potentiates guanine nucleotide exchange factor CDC25 and SOS1 activation of ras transforming activity. Proc. Natl Acad. Sci. USA 91:8512-8516.
36. Reichman, C. T., B. J. Mayer, S. Keshau, and H. Hanafusa. 1992. The product of the cellular crk gene consists primarily of SH2 and SH3 regions Cell Growth Differ 3:451-460.
37. Richardson, A., and J. T. Parsons. 1995 Signal transduction through integrins: a central role for focal adhesion kinase? Bioessays 17:229-236.
38. Sakai, R., A. Iwamatsu, N. Hirano, S. Ogawa, T. Tanaka, H. Mano, Y. Yazaki, and H. Hirai. 1994. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 13:3748-3756.
39. Sawasdikosol, S., K. S. Ravichandran, K. K. Lee, J.-H. Chang, and S. J. Burakoff. 1995. Crk interacts with tyrosine-phosphorylated p116 upon T cell activation. J. Biol. Chem. 270:2893-2896.
40. Schaller, M. D., and J. T. Parsons. 1994. Focal adhesion kinase and associated proteins. Curr. Opin. Cell Biol. 6:705-710.
41. FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk. Mol Cell. Biol. 15:2635-2645.
42. Schlaepfer, D. D., S. K. Hanks, T. Hunter, and P. Vandergeer. 1994. Integrin-mediated signal transduction linked to ras pathway by GRB2 binding to focal adhesion kinase. Nature (London) 372:786-791.
43. Schumacher, C., B. S. Knudsen, T. Ohuchi, P. P. Difiore, R. H. Glassman, and H. Hanafusa. 1995. The SH3 domain of crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R J. Biol. Chem. 270: 15341-15347.
44. Tanaka, S., S. Hattori, T. Kurata, K. Nagashima, Y. Fukui, S. Nakamura, and M. Matsuda. 1993 Requirement of both the SH2 and SH3 domains for neuronal differentiation of PC12 cells induced by human CRK protein Mol Cell. Biol. 13:4409-4415.
45. Tanaka, S., T. Morishita, Y. Hashimoto, S. Hattori, S. Nakamura, T. Takenawa, K. Matuoka, M. Shibuya, T. Kurata, K. Nagashima, and M. Matsuda. 1994. C3G, a guanine nucleotide releasing protein, binds to the SH3 domains of CRK and ASH/GRB2. Proc. Natl. Acad. Sci. USA 91:3443-3447.